Distribution, Manufacturing and Inspection

Information about the interruption in manufacturing and supply chain with Norcuron 4 mg powder for solution for injection or infusion (vecuronium bromide)

03.03.2014

The marketing authorisation holder for Norcuron 4 mg powder for solution for injection or infusion (vecuronium bromide), Merck Sharp & Dohme d.o.o., has informed the Agency for Medicinal Products and Medical Devices (HALMED) on the interruption in manufacturing and supply chain of the Croatian market with this medicine and revocation of the marketing authorisation.

Further information is accessible under the link below.

more

Information about the interruption in manufacturing and supply chain with Sodium Hydrogen Carbonate Pliva 84 mg/ml solution for infusion

03.03.2014

The marketing authorisation holder for Sodium Hydrogen Carbonate Pliva 84 mg/ml solution for infusion, Pliva Hrvatska d.o.o., has informed the Agency for Medicinal Products and Medical Devices (HALMED) on the interruption in manufacturing and supply chain of the Croatian market with this medicine and revocation of the marketing authorisation.

Further information is accessible under the link below.

more

Workshop: “Regulatory framework in medicinal products distribution”

27.02.2014

The Agency for Medicinal Products and Medical Devices (HALMED) is organising in Zagreb, a one day workshop “Regulatory framework in medicinal products distribution” intended to wholesales authorisation holders. Workshops will be held at HALMED’s premises, Ksaverska cesta 4. The exact date of the first workshop will be announced later, depending on the number of registered participants.
Detailed information is available under the link below.

more

For Patients and Public

For Health Care Professionals

For Industry Representatives